A detailed history of Longbow Finance Sa transactions in Mi Nk Therapeutics, Inc. stock. As of the latest transaction made, Longbow Finance Sa holds 166,666 shares of INKT stock, worth $113,332. This represents 0.01% of its overall portfolio holdings.

Number of Shares
166,666
Previous 166,666 -0.0%
Holding current value
$113,332
Previous $158 Million 20.99%
% of portfolio
0.01%
Previous 0.02%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 08, 2024

BUY
$0.88 - $1.21 $146,666 - $201,665
166,666 New
166,666 $178 Million
Q4 2022

Feb 13, 2023

BUY
$1.89 - $3.16 $314,998 - $526,664
166,666 New
166,666 $435 Million

Others Institutions Holding INKT

About MiNK Therapeutics, Inc.


  • Ticker INKT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,775,100
  • Market Cap $23M
  • Description
  • MiNK Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of allogeneic, off-the-shelf, invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. Its product candidate is AGENT-797, an off-the-shelf, allogeneic for iNKT cell therapy...
More about INKT
Track This Portfolio

Track Longbow Finance Sa Portfolio

Follow Longbow Finance Sa and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Longbow Finance Sa, based on Form 13F filings with the SEC.

News

Stay updated on Longbow Finance Sa with notifications on news.